PE Firm Shore Capital Partners Sells Argentum Medical to BioDerm

PE Firm Shore Capital Partners Sells Argentum Medical to BioDerm

by | Feb 7, 2023 12:58 pm | Medical Devices, Private Equity | 0 comments

Chicago-based private equity firm Shore Capital Partners announced the sale of Argentum Medical to BioDerm, a portfolio company of Denver-based private equity firm Mountaingate Capital. The transaction closed on January 31, 2023. Moelis & Company served as financial advisor to Argentum and Winston & Strawn LLP served as legal advisor to Shore and Argentum. Terms of the deal were not disclosed. Based in Geneva, Illinois, Argentum is a provider of infection prevention solutions for the management of wounds. Notably, it manufactures Silverlon, a silver-plated nylon dressing with unique antimicrobial properties. Argentum’s product lines include surgical, burn care, wound care, negative... Read More »
BioScrip and Option Care Merge

BioScrip and Option Care Merge

by | Mar 22, 2019 3:34 pm | Home Health & Hospice | 0 comments

BioScrip (NASDAQ: BIOS) and Option Care announced they are merging in perhaps the biggest home health deal of 2019 so far. Option Care provides home and alternate treatment site infusion services and is owned by Madison Dearborn Partners, LLC (MDP) and Walgreens Boots Alliance, Inc. (NASDAQ: WBA). BioScrip offers infusion and home care management solutions, and as one of the largest nationwide providers, it services nearly 70 service locations nationwide. It partners with physicians, hospital systems,  and skilled nursing facilities to provide patients access to post-acute care services. BioScrip has made a few significant acquisitions itself over the past few years worth noting. It... Read More »

Dentsply Sirona Picks Up MIS Implants

by | Jun 30, 2016 8:00 am | Medical Devices | 0 comments

Just last September, Dentsply International (NASDAQ: XRAY) acquired Sirona Dental Systems (NASDAQ: SIRO) for $5.5 billion in an all-stock transaction. The acquisition added Sirona’s worldwide dental equipment business, which posted revenues of $1.15 billion (4.8x) on a trailing 12-month basis, and EBITDA of $280 million (19.8x). The transaction created the world’s largest maker of professional dental products and technologies, with net revenue of approximately $3.8 billion and adjusted EBITDA of more than $900 million on pro forma basis. Nine months later, the combined company, now known as Dentsply Sirona Inc., purchased the Israeli dental implant maker MIS Implants... Read More »